ArticleThe journal of headache and pain2021

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.

Fenne Vandervorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.